Follow-up study for people previously given ALLO-ASC-CD
Part of Digestive system clinical trials.
This study checks the long-term safety of ALLO-ASC-CD in people who already received it in an earlier phase 1 trial. It may help confirm that the treatment remains safe over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have previously been injected with ALLO-ASC-CD in the earlier ALLO-ASC-CD-101 phase 1 study
- You can sign a written consent form before starting this study
- You can follow the study’s visit and testing instructions
- Your study doctor must agree that you are suitable to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This trial tests a low dose of IL-2 to reduce inflammation and help control Crohn’s disease symptoms. It’s for people whose Crohn’s disease hasn’t responded to at least one standard treatment or who need steroids to stay under control.
This Phase 1 trial tests whether an IV infusion of donated (allogeneic) stem cells is safe in people with Crohn’s disease or ulcerative colitis. It focuses mainly on safety and tolerability, and it may offer a new treatment approach if you qualify.
This trial tests a new treatment called L2-01 for people who were recently diagnosed with Crohn's disease and whose disease is currently in remission. The goal is to see if it can help prevent flares and keep you feeling well.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.